Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prosthetic valve endocarditis: a continuing challenge for infection control.

A W Karchmer1

  • 1Department of Medicine, New England Deaconess Hospital, Boston, Massachusetts 02215.

The Journal of Hospital Infection
|June 1, 1991
PubMed
Summary

Nosocomial prosthetic valve endocarditis (PVE) risk is higher than previously thought, occurring up to a year post-surgery. Methicillin-resistant staphylococci are the main cause, necessitating further research into prevention strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2009
Same author

Outcomes of antifungal prophylaxis in high-risk liver transplant recipients.

Transplant infectious disease : an official journal of the Transplantation Society·2009
Same author

Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.

The Journal of antimicrobial chemotherapy·2007
Same author

Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients.

Emerging infectious diseases·2004
Same author

Adequacy of fellowship training: results of a survey of recently graduated fellows.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001

Area of Science:

  • Cardiovascular Surgery
  • Infectious Diseases
  • Medical Microbiology

Background:

  • Conventional estimates for nosocomial prosthetic valve endocarditis (PVE) risk range from 0.7-1.4% within months post-surgery.
  • Recent actuarial analyses indicate a higher PVE risk of 1.4-3.0%, with occurrences throughout the first year after surgery.

Purpose of the Study:

  • To analyze the incidence and causative agents of nosocomial prosthetic valve endocarditis (PVE).
  • To evaluate current prophylactic antibiotic strategies and identify areas for improved PVE prevention.

Main Methods:

  • Review of recent clinical series and actuarial data on nosocomial PVE incidence.
  • Analysis of predominant microbial causes, particularly methicillin-resistant coagulase-negative staphylococci.
  • Evaluation of prophylactic antibiotic efficacy, including cefazolin, cefamandole, cefuroxime, and vancomycin.

Related Experiment Videos

Main Results:

  • Methicillin-resistant coagulase-negative staphylococci, primarily Staphylococcus epidermidis, are responsible for 60% of nosocomial PVE cases.
  • Intraoperative contamination has been linked to PVE outbreaks.
  • Current evidence does not definitively support cefamandole or cefuroxime over cefazolin for PVE prophylaxis; vancomycin requires further study.

Conclusions:

  • The incidence of nosocomial PVE is likely underestimated, with risks extending throughout the first year post-surgery.
  • Aseptic techniques are fundamental, but further research is needed to identify modifiable perioperative and postoperative care elements to reduce PVE.
  • Optimizing prophylactic antibiotic regimens is crucial for preventing PVE, with ongoing investigation into optimal agents and protocols.